Bristol Myers Squibb
New York, New York, United States · Biopharma, Biotechnology, Health Care
Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information about Bristol Myers Squibb, visit us at BMS.com or follow us on LinkedIn, Twitter, YouTube, Facebook, and Instagram.
Key facts
- Headquarters
- New York, New York, United States
- Employees
- 33,000
- Industries
- Biopharma, Biotechnology, Health Care
- Status
- Public (BMY)
- Website
- bms.com
- Company page
Recent activity at Bristol Myers Squibb
- : Bristol Myers Squibb acquires Celgene for $74B
- : Bristol Myers Squibb Ends Partnership with Cellares Over CAR-T Therapy Manufacturing Challenges.
- : Bristol-Myers acquires Medarex for cancer pipeline
- : Bristol Myers Squibb Appoints Mayada Al-Ahmad as General Manager of Saudi Arabia and Gulf Countries
- : Bristol-Myers Squibb Partners With Anthropic to Enhance Drug Discovery Through AI
- : Bristol Myers Squibb partners with Hengrui Pharma for a multi-billion dollar collaboration to develop new drugs.
- : Bristol Myers Squibb to acquire Karuna Therapeutics
- : Bristol Myers Squibb Appoints Harald Hampel as Senior VP Worldwide Head of Medical Affairs.
- : Bristol Myers Squibb Signs Agreement with U.S. Government to Provide Eliquis for Free to Medicaid Program
- : SEC 8-K (2.01): On November 3, 2025, Bristol-Myers Squibb Company announced the commencement of cash tender offers to purchase certain of its outstanding notes for an aggregate purchase price of up to $7 billion. The tender offers are categorized into two pools, subject to the Pool 1 Maximum and Pool 2 Maximum as detailed in the company's Offer to Purchase dated the same day. This move signals Bristol-Myers Squibb's strategic initiative to manage debt and optimize capital structure, emphasizing their commitment to financial flexibility. The Offers are contingent upon meeting specific terms and conditions outlined in the Offer to Purchase document.
Leadership
- Alejandra Allard, HR Director Mexico, Colombia & Peru
- Mayada Al-Ahmad, Manager
- Jon Glines, Specialty Sales Representative
- Cosimo Vavallo, Product Specialist-Immuno Oncology
- Meg Anderson, Vice President, Neurology and Gi Immunology Sales & Marketing
- Carole Bertola, Director Global Strategic Sourcing & Procurement
- Vanessa E Hasle, Principal Scientist
- Raquel Pinacho Castro, Marketing Strategist Hematology
- Jacob Zalaznick, Principal Scientist
- Kevin Luis Snyder, Associate Director, Early Career Talent Acquisition
- Carlos Cuadrado, Senior Manager, Business Development Analytics
- Evelin Silva, Procurement Sr Manager Latam
Verified email and direct lines for Bristol Myers Squibb’s decision-makers are on Fundz. See plans
Employee benefit plans
Bristol Myers Squibb files 49 employee benefit plans with the U.S. Department of Labor, including a retirement plan. The next plan year renews in Dec 2026.
Bristol Myers Squibb in the news
- Bristol Myers Squibb employees cycle across four continents to advance cancer research - Bristol Myers Squibb (Jun 30, 2026)
- Bristol Myers Squibb Advances U.S. Manufacturing Investment with New $2.3 Billion Campus in Houston, Texas - Business Wire (Aug 10, 2026)
- UPDATED: Novartis halts autoimmune CAR-T trials after 3 deaths, as BMS also pauses studies - Fierce Biotech (Aug 31, 2026)
- U.S. FDA Grants Accelerated Approval to Bristol Myers Squibb's First CELMoD Therapy ZENBEXUS™, in Combination with Daratumumab and Hyaluronidase-fihj and Dexamethasone (ZDd) for Patients with Multiple Myeloma, as Early as First Relapse - Bristol Myers Squibb (Aug 13, 2026)
- BMS-Claude Agreement Signals AI Integration Shift in Pharma - Pharmaceutical Commerce (May 21, 2026)
- BMS-Anthropic Signals AI Move in Drug Manufacturing Quality Systems - PharmTech.com (May 21, 2026)
- JP Morgan 2026 Preview: Bristol Myers Squibb’s Continued Growth - Pharmaceutical Executive (Dec 24, 2025)
- Bristol Myers Squibb Appoints Osama Braiwish as General Manager for Saudi Arabia & Gulf Countries - PR Newswire (Mar 20, 2025)
Companies similar to Bristol Myers Squibb
- Abivax · Biopharma, Biotechnology, Health Care, Legal, Medical, Pharmaceutical, Therapeutics
- Jazz Pharmaceuticals plc · Biopharma, Biotechnology, Health Care, Manufacturing, Pharmaceutical, Therapeutics
- Innovent Biologics (Innovent) · Biopharma, Biotechnology, Health Care, Manufacturing, Pharmaceutical, Therapeutics
- Tarsus Pharmaceuticals · Biopharma, Biotechnology, Health Care, Manufacturing, Pharmaceutical, Therapeutics
- MacroGenics · Biopharma, Biotechnology, Health Care, Manufacturing, Pharmaceutical, Therapeutics
About Bristol Myers Squibb: questions and answers
What does Bristol Myers Squibb do?
Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information about Bristol Myers Squibb, visit us at BMS.com or follow us on LinkedIn, Twitter, YouTube, Facebook, and Instagram.
Where is Bristol Myers Squibb headquartered?
Bristol Myers Squibb is headquartered in New York, New York, United States.
How many employees does Bristol Myers Squibb have?
Bristol Myers Squibb has about 33,000 employees.
Who leads Bristol Myers Squibb?
Meg Anderson is a Vice President, Neurology and Gi Immunology Sales & Marketing at Bristol Myers Squibb.
What is the latest news on Bristol Myers Squibb?
On Aug 31, 2026, Bristol Myers Squibb acquires Celgene for $74B
Is Bristol Myers Squibb a public company?
Yes. Bristol Myers Squibb is publicly traded under the ticker BMY.
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy